1.
Kotsos D, Gradowska P, Hermans SJ, Pabst T, Maertens J, Manz M, Breems DA, Gertsen BT, Lehmann S, Biemond BJ, Beverloo BH, Valk PJ, Janssen JJ, Ossenkoppele G, Löwenberg B, Huls G, Raaijmakers MH, Versluis. J. Treatment of therapy-related acute myeloid leukemia and acute myeloid leukemia with myelodysplasia-related changes: a comparative analysis of higher-dose intensive 7+3 induction chemotherapy versus liposomal cytarabine and daunorubicin. haematol [Internet]. 2020Sep.10 [cited 2026Mar.29];. Available from: https://haematologica.org/article/view/13423